BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27879149)

  • 1. Increasing amount of amyloid are associated with the severity of clinical features in hereditary gelsolin (AGel) amyloidosis.
    Pihlamaa T; Suominen S; Kiuru-Enari S; Tanskanen M
    Amyloid; 2016 Dec; 23(4):225-233. PubMed ID: 27879149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutis laxa in hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Keski-Oja J; Haltia M
    Br J Dermatol; 2005 Feb; 152(2):250-7. PubMed ID: 15727635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid in parenchymal organs in gelsolin (AGel) amyloidosis.
    Schmidt EK; Kiuru-Enari S; Atula S; Tanskanen M
    Amyloid; 2019 Sep; 26(3):118-124. PubMed ID: 31122115
    [No Abstract]   [Full Text] [Related]  

  • 4. Hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Haltia M
    Handb Clin Neurol; 2013; 115():659-81. PubMed ID: 23931809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular pathology in hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Somer H; Seppäläinen AM; Notkola IL; Haltia M
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):565-71. PubMed ID: 12071640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xerostomia in hereditary gelsolin amyloidosis.
    Juusela P; Tanskanen M; Nieminen A; Kari K; Suominen L; Uitto VJ; Kiuru-Enari S
    Amyloid; 2013 Mar; 20(1):39-44. PubMed ID: 23356404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe elastolysis in hereditary gelsolin (AGel) amyloidosis.
    Koskelainen S; Zhao F; Kalimo H; Baumann M; Kiuru-Enari S
    Amyloid; 2020 Jun; 27(2):81-88. PubMed ID: 31814469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe ataxia with neuropathy in hereditary gelsolin amyloidosis: a case report.
    Tanskanen M; Paetau A; Salonen O; Salmi T; Lamminen A; Lindsberg P; Somer H; Kiuru-Enari S
    Amyloid; 2007 Mar; 14(1):89-95. PubMed ID: 17453628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in the clinical course of Finnish gelsolin amyloidosis.
    Atula S; Nikoskinen T; Saastamoinen A; Strbian D; Schmidt EK; Kiuru-Enari S
    Amyloid; 2016; 23(1):33-8. PubMed ID: 26805765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary gelsolin amyloidosis mimicking Sjögren's syndrome.
    Juusela P; Tanskanen M; Nieminen A; Uitto VJ; Blåfield H; Kiuru-Enari S
    Clin Rheumatol; 2009 Nov; 28(11):1351-4. PubMed ID: 19701715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study.
    Schmidt EK; Mustonen T; Kiuru-Enari S; Kivelä TT; Atula S
    Orphanet J Rare Dis; 2020 Jan; 15(1):19. PubMed ID: 31952544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary gelsolin amyloidosis (HGA): a neglected cause of bilateral progressive or recurrent facial palsy.
    Sagnelli A; Piscosquito G; Di Bella D; Fadda L; Melzi L; Morico A; Ciano C; Taroni F; Facchetti D; Salsano E; Pareyson D
    J Peripher Nerv Syst; 2017 Mar; 22(1):59-63. PubMed ID: 27982499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The First Korean Family With Hereditary Gelsolin Amyloidosis Caused by p.D214Y Mutation in the GSN Gene.
    Park KJ; Park JH; Park JH; Cho EB; Kim BJ; Kim JW
    Ann Lab Med; 2016 May; 36(3):259-62. PubMed ID: 26915616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary gelsolin amyloidosis: a rare cause of cranial, peripheral and autonomic neuropathies linked to D187N and Y447H substitutions.
    Mendelson L; Prokaeva T; Lau KHV; Sanchorawala V; McCausland K; Spencer B; Dasari S; McPhail ED; Kaku MC
    Amyloid; 2023 Dec; 30(4):357-363. PubMed ID: 37140928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary gelsolin amyloidosis--40 years of Meretoja disease].
    Kiuru-Enari S; Haltia M
    Duodecim; 2010; 126(10):1162-71. PubMed ID: 20597346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Histopathological Features of Gelsolin Amyloidosis Associated with a Novel
    Potrč M; Volk M; de Rosa M; Pižem J; Teran N; Jaklič H; Maver A; Drnovšek-Olup B; Bollati M; Vogelnik K; Hočevar A; Gornik A; Pfeifer V; Peterlin B; Hawlina M; Fakin A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Invasive Imaging of Amyloid Deposits in a Mouse Model of AGel Using
    Verhelle A; Van Overbeke W; Peleman C; De Smet R; Zwaenepoel O; Lahoutte T; Van Dorpe J; Devoogdt N; Gettemans J
    Mol Imaging Biol; 2016 Dec; 18(6):887-897. PubMed ID: 27130233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurological manifestations of AGel amyloidosis (Meretoja's syndrome) in a German family].
    Bürmann J; Fassbender K; Henn W; Lohse P; Holzhoffer C; Fassbender K; Dillmann U
    Fortschr Neurol Psychiatr; 2011 Apr; 79(4):238-41. PubMed ID: 21480154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtle neuropsychiatric and neurocognitive changes in hereditary gelsolin amyloidosis (AGel amyloidosis).
    Kantanen M; Kiuru-Enari S; Salonen O; Kaipainen M; Hokkanen L
    PeerJ; 2014; 2():e493. PubMed ID: 25097823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational Design of a Peptidomimetic Inhibitor of Gelsolin Amyloid Aggregation.
    Bollati M; Peqini K; Barone L; Natale C; Beeg M; Gobbi M; Diomede L; Trucchi M; de Rosa M; Pellegrino S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.